Bloop Hemorrhoid Relief Topical Cream
NDC Package 83838-155-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bloop Hemorrhoid Relief Topical (glycerin, petrolatum, phenylephrine hcl, pramoxine hcl) cream is helps relieve the pain, itching, and burning associated with hemorrhoids and other anorectal disordersTemporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful from irritation and abrasion during bowel movement.Temporarily shrinks hemorrhoidal tissue. This formulation utilizes a cream delivery system. Marketed by Three Nations Corp, this product is identified by NDC 83838-155 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
83838-155-01
Package Description
1 TUBE in 1 BOX / 28 g in 1 TUBE
Product Code
83838-155
11-Digit Billing Format
83838015501
RxNorm Crosswalk
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine HCl 0.25 % / pramoxine HCl 1 % / white petrolatum 15 % Rectal Cream
  • RxCUI: 1293649 - glycerin 144 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 15 % Rectal Cream

Clinical Specifications

Proprietary Name
Bloop Hemorrhoid Relief Topical
Non-Proprietary Name
Glycerin, Petrolatum, Phenylephrine Hcl, Pramoxine Hcl
Substance Name
Glycerin; Petrolatum; Phenylephrine Hydrochloride, (+/-)-; Pramoxine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Helps relieve the pain, itching, and burning associated with hemorrhoids and other anorectal disordersTemporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful from irritation and abrasion during bowel movement.Temporarily shrinks hemorrhoidal tissue.

Regulatory & Marketing

Labeler Name
Three Nations Corp
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-14-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83838-155-01 identifies a specific commercial package of 1 tube in 1 box / 28 g in 1 tube of Bloop Hemorrhoid Relief Topical, a human over the counter drug labeled by Three Nations Corp. This cream is formulated for topical use and contains glycerin; petrolatum; phenylephrine hydrochloride, (+/-)-; pramoxine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Three Nations Corp on November 14, 2023. The current certification is valid through December 31, 2026.

How is this Three Nations Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83838015501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83838-155-01
11-Digit CMS (5-4-2)
83838-0155-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.